Another study involving 530 patients evaluated the utility of serial measurements of [TIMP-2]•[IGFBP7] for predicting AKI stage 2–3: the biomarkers were measured every 12 h during the first 72 h after ICU admission. This evidence concerns the gene TIMP2 and acute kidney injury.